Radiopharmaceutical company Cyclopharm (ASX: CYC) is set to begin commercial sales of its lung imaging device Technegas in the US,…
Following a particularly well received first phase of their clinical pilot program, medical technology company 4DMedical (ASX: 4DX) is advancing…
Investors that missed out on the IPO for medtech company 4D Medical (ASX: 4DX) have had no qualms buying the…
While the number of companies set to list on the ASX is still quieter than usual, we are continuing to…